John Theurer Cancer Center at Jersey Shore University Medical Center

Advanced Oncology Care Close to Home from New Jersey’s Best Cancer Program

John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC) - the largest and most comprehensive cancer center in New Jersey - is now expanding its program to HOPE Tower at Jersey Shore University Medical Center (JSUMC). The expansion will allow JTCC to offer advanced cancer care closer to home for patients in south and central New Jersey, establishing one comprehensive program with two locations. In addition to on site resources, cancer patients at JSUMC have access to medical innovations and clinical trials at JTCC in Hackensack. 

Building upon JSUMC’s foundation of excellent cancer care and its comprehensive oncology program, the JTCC expansion will connect patients with treatments for advanced cancer care that were previously not available in south and central New Jersey. New specialized services include:

Leukemia care

Patients with acute and chronic leukemia now have access to clinical expertise, innovation, clinical trials, and bone marrow transplantation services at JSUMC.

Bone marrow transplantation and cell therapy

Patients have access to inpatient stem cell and bone marrow transplantation and related outpatient care, as well as the latest cell therapy treatments including chimeric antigen receptor T-cell (CAR-T) therapy.

Phase I clinical trials

Through its Phase I clinical trials program - the largest in New Jersey - JTCC offers needed options when standard therapies fail – particularly drugs in early development phase including first-in-human clinical trials. JSUMC’s patients will now have access to JTCC’s Phase I clinical trials in experimental drug discovery and therapeutics, including targeted therapies, immuno-oncology, and CAR-T trials.